RetractedArticleMolecular cancer therapeutics2014

In vitro and in vivo interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib in non-Hodgkin lymphoma cells.

Girija Dasmahapatra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.